[1]
|
K. Blessing, N. M. Kernohan and K. G. M. Park, “Subungual Malignant Melanoma: Clinicopathological Features of 100 Cases,” Histopathology, Vol. 19, No. 5, 1991, pp. 425-429. doi:10.1111/j.1365-2559.1991.tb00232.x
|
[2]
|
A. I. Riker, N. Zea and T. Trinh, “The Epidemiology, Prevention, and Detection of Melanoma,” The Ochsner Journal, Vol. 10, 2010, pp. 56-65.
|
[3]
|
Banfield and Dawber, “Nail Melanoma: A Review of the Literature with Recommendations to Improve Patient Management,” British Journal of Dermatology, Vol. 141, No. 4, 1999, pp. 628-632.
doi:10.1046/j.1365-2133.1999.03099.x
|
[4]
|
K. E. Thai, R. Young and S. Rd, “Nail Apparatus Melanoma,” Australasian Journal of Dermatology, Vol. 42, No. 2, 2001, pp. 71-83.
|
[5]
|
V. K. Shukla and L. E. Hughes, “Differential Diagnosis of Subungual Melanoma from a Surgical Point of View,” British Journal of Surgery, Vol. 76, No. 11, 1989, pp. 1156-1160. doi:10.1002/bjs.1800761115
|
[6]
|
Banfield, Redburn and Dawber, “The Incidence and Prognosis of Nail Apparatus Melanoma. A Retrospective Study of 105 Patients in Four English Regions,” British Journal of Dermatology, Vol. 139, No. 2, 1998, pp. 276-279. doi:10.1046/j.1365-2133.1998.02365.x
|
[7]
|
R. H. Patterson and E. B. Helwig, “Subungual Malignant Melanoma: A Clinical-Pathologic Study,” Cancer, Vol. 46, No. 9, 1980, pp. 2074-2087.
doi:10.1002/1097-0142(19801101)46:9<2074::AID-CNCR2820460928>3.0.CO;2-K
|
[8]
|
C. M. Balch, S. J. Soong, et al., “An Analysis of Prognostic Factors in 8500 Patients with Cutaneous Melanoma,” In: C. M. Balch, A. N. Houghton, G. W. Milton, A. J. Sober and S.-J. Soong, Eds., Cutaneous Melanoma, Lippincott, Philadelphia, 1992, pp. 165-187.
|
[9]
|
W. A. G. Bruls, H. Slaper, J. C. Van Der Leun and L. Berrens, “Transmission of Human Epidermis and Stratum Corneum as a Function of Thickness in the Ultraviolet and Visible Wavelengths,” Photochemistry and Photobiology, Vol. 40, No. 4, 1984, pp. 485-494.
doi:10.1111/j.1751-1097.1984.tb04622.x
|
[10]
|
H. Takematsu, M. Obata, Y. Tomita, T. Kato, M. Takahashi and R. Abe, “Subungual Melanoma: A Clinicopathologic Study of 16 Japanese Cases,” Cancer, Vol. 55, No. 11, 1985, pp. 2725-2731.
doi:10.1002/1097-0142(19850601)55:11<2725::AID-CNCR2820551134>3.0.CO;2-V
|
[11]
|
D. A. Hudson, J. E. J. Krige, R. M. Strover and H. S. King, “Subungual Melanoma of the Hand,” Journal of Hand Surgery, Vol. 15, No. 3, 1990, pp. 288-290.
doi:10.1016/0266-7681(90)90005-O
|
[12]
|
M. M?hrle and H. M. H?fner, “Is Subungual Melanoma Related to Trauma?” Dermatology, Vol. 204, No. 4, 2002, pp. 259-261. doi:10.1159/000063354
|
[13]
|
J. A. O’Leary, K. R. Berend, J. L. Johnson, L. S. Levin and H. F. Seigler, “Subungual Melanoma. A Review of 93 Cases with Identification of Prognostic Variables,” Clinical Orthopaedics and Related Research, Vol. 378, 2000, pp. 206-212.
|
[14]
|
T. Cohen, K. J. Busam, A. Patel and M. S. Brady, “Subungual Melanoma: Management Considerations,” American Journal of Surgery, Vol. 195, No. 2, 2008, pp. 244-248. doi:10.1016/j.amjsurg.2007.03.010
|
[15]
|
E. K. Levit, M. H. Kagen, R. K. Scher, M. Grossman and E. Altman, “The ABC Rule for Clinical Detection of Subungual Melanoma,” Journal of the American Academy of Dermatology, Vol. 42, No. 2, 2000, pp. 269-274.
|
[16]
|
R. K. Scher and D. N. Silvers, “Longitudinal Melanonychia Striata,” Journal of the American Academy of Dermatology, Vol. 24, No. 6, 1991, pp. 1035-1036.
doi:10.1016/S0190-9622(08)80136-3
|
[17]
|
M. J. Quinn, J. E. Thompson, K. Crotty, W. H. McCarthy and A. S. Coates, “Subungual Melanoma of the Hand,” The Journal of Hand Surgery, Vol. 21, No. 3, 1996, pp. 506-511. doi:10.1016/S0363-5023(96)80371-6
|
[18]
|
A. B. Ackerman, “Conventional Microscopy: Signs That Stamp Pigmented Melanocytic Nevi as Benign,” American Journal of Dermatopathology, Vol. 4, No. 5, 1982, pp. 461-466. doi:10.1097/00000372-198210000-00015
|
[19]
|
T. Kato, Y. Usuba, H. Takematsu, N. Kumasaka, Y. Tanita, K. Hashimoto, Y. Tomita and H. Tagami, “A Rapidly Growing Pigmented Nail Streak Resulting in Diffuse Melanosis of the Nail. A Possible Sign of Subungual Melanoma in situ,” Cancer, Vol. 64, No. 10, 1989, pp. 2191-2197.
doi:10.1002/1097-0142(19891115)64:10<2191::AID-CNCR2820641035>3.0.CO;2-D
|
[20]
|
R. Baran and P. Kechijian, “Hutchinson’s Sign: A Reappraisal,” Journal of the American Academy of Dermatology, Vol. 34, No. 1, 1996, pp. 87-90.
doi:10.1016/S0190-9622(96)90839-7
|
[21]
|
B. S. Ruben, “Pigmented Lesions of the Nail Unit: Clinical and Histopathologic Features,” Seminars in Cutaneous Medicine and Surgery, Vol. 29, No. 3, 2010, pp. 148-158. doi:10.1016/j.sder.2010.06.008
|
[22]
|
J. W. Kelly, J. M. Yeatman, C. Regalia, G. Mason and H. Ap, “A High Incidence of Melanoma Found in Patients with Multiple Dysplastic Naevi by Photographic Surveillance,” Medical Journal of Australia, Vol. 167, 1997, pp. 191-194.
|
[23]
|
M. Izumi, K. Ohara, T. Hoashi, H. Nakayama, C.-S. Chiu, T. Nagai, J. Matsubayashi, K. Iwaya and K. Mukai, “Subungual Melanoma: Histological Examination of 50 Cases from Early Stage to Bone Invasion,” The Journal of Dermatology, Vol. 35, No. 11, 2008, pp. 695-703.
doi:10.1111/j.1346-8138.2008.00551.x
|
[24]
|
G. Massi, P. E. Leboit and E. Al, “Melanoma on Palms, Soles and Subungual Melanoma—Acral Melanoma,” In: D. Massi and P. Leboit, Eds., Histological Diagnosis of Nevi and Melanoma, Springer, 2004, p. 577.
doi:10.1007/978-3-7985-1943-5
|
[25]
|
R. A. Scolyer, J. F. Thompson, S. W. McCarthy, G. M. Strutton and D. E. Elder, “Incomplete Biopsy of Melanocytic Lesions Can Impair the Accuracy of Pathological Diagnosis,” Australasian Journal of Dermatology, Vol. 47, No. 1, 2006, pp. 71-73.
|
[26]
|
A. Piris, M. C. Mihm Jr. and L. M. Duncan, “AJCC Melanoma Staging Update: Impact on Dermatopathology Practice and Patient Management,” Journal of Cutaneous Pathology, Vol. 38, No. 5, 2011, pp. 394-400.
doi:10.1111/j.1600-0560.2011.01699.x
|
[27]
|
J. Hutchinson, “Melanosis Often Not Black: Melanotic Whitlow,” British Medical Journal, Vol. 1, 1886, p. 491.
|
[28]
|
K. M. Heaton, A. El-Naggar, L. G. Ensign, M. I. Ross and B. Cm, “Surgical Management and Prognostic Factors in Patients with Subungual Melanoma,” Annals of Surgery, Vol. 219, No. 2, 1994, pp. 197-204.
doi:10.1097/00000658-199402000-00012
|
[29]
|
K. G. M. Park, K. Blessing and K. Nm, “Surgical Aspects of Subungual Malignant Melanomas,” Annals of Surgery, Vol. 216, 1992, pp. 692-695.
doi:10.1097/00000658-199212000-00012
|
[30]
|
F. H. Sim, W. F. Taylor, D. J. Pritchard and S. Eh, “Lymphadenectomy in the Management of Stage I Malignant Melanoma: A Prospective Randomized Study,” Mayo Clinic Proceedings, Vol. 61, 1986, pp. 697-705.
|
[31]
|
N. Cascinelli, A. Morabito, M. Santinami, R. M. Mackie and F. Belli, “Immediate or Delayed Dissection of Regional Nodes in Patients with Melanoma of the Trunk: A Randomised Trial,” Lancet, Vol. 351, No. 9105, 1998, pp. 793-796. doi:10.1016/S0140-6736(97)08260-3
|
[32]
|
R. K. Finley 3rd, D. L. Driscoll, L. E. Blumenson and K. Cp, “Subungual Melanoma: An Eighteen-Year Review,” Surgery, Vol. 116, 1994, pp. 96-100.
|
[33]
|
M. Moehrle, S. Metzger, W. Schippert, C. Garbe, G. Rassner and H. Breuninger, “‘Functional’ Surgery in Subungual Melanoma,” Dermatologic Surgery, Vol. 29, 4, 2003, pp. 366-374.
doi:10.1046/j.1524-4725.2003.29087.x
|
[34]
|
U. Veronesi, N. Cascinelli, J. Adamus, C. Balch, D. Bandiera, A. Barchuk, R. Bufalino, P. Craig, J. De Marsillac, J. C. Durand and E. Al, “Thin Stage I Primary Cutaneous Malignant Melanoma. Comparison of Excision with Margins of 1 or 3 cm,” New England Journal of Medicine, Vol. 318, 1988, pp. 1159-1162.
doi:10.1056/NEJM198805053181804
|
[35]
|
C. M. Balch, S.-J. Soong, T. Smith, M. I. Ross, M. M. Urist, C. P. Karakousis, W. J. Temple, M. C. Mihm, R. L. Barnhill, W. R. Jewell, et al., “Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients with 1 - 4 mm Melanomas,” Annals of Surgical Oncology, Vol. 8, No. 2, 2001, pp. 101-108.
|
[36]
|
J. M. Thomas, J. Newton-Bishop, R. A’hern, G. Coombes, M. Timmons, J. Evans, M. Cook, J. Theaker, M. Fallowfield, T. O’neill, W. Ruka and J. M. Biss, “Excision Margins in High-Risk Malignant Melanoma,” New England Journal of Medicine, Vol. 350, 2004, pp. 757-766.
doi:10.1056/NEJMoa030681
|
[37]
|
D. L. Morton, J. F. Thompson, A. J. Cochran, N. Mozzillo, R. Elashoff, R. Essner, O. E. Nieweg, D. F. Roses, H. J. Hoekstra, C. P. Karakousis, D. S. Reintgen, B. J. Coventry, E. C. Glass and H. J. Wang, “Sentinel- Node Biopsy or Nodal Observation in Melanoma,” New England Journal of Medicine, Vol. 355, 2006, pp. 1307-1317.
|
[38]
|
J. Weber, “Immunotherapy for Melanoma,” Current Opinion in Oncology, Vol. 23, 2011, pp. 163-169.
doi:10.1097/CCO.0b013e3283436e79
|